Key Insights

Highlights

Treatment Research

1 treatments under study, led by Drug Eluting Stent

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
NCT01122719Not ApplicableTerminated

Brazilian and Italian Evaluation of Safety Using Tacrolimus-eluting Stent With Short-term Dual Antiplatelet Regimen

Showing all 1 trials

Research Network

Common Treatments

  • Drug Eluting Stent1

Active Sponsors

  • Contract research Organization: Cardiovascular Research Center - Sao Paulo, Brazil1
  • CID - Carbostent & Implantable Devices1

Top Investigators

Related Conditions

  • Stable Coronary Disease1
  • Documented Silent Ischemia1

Activity Timeline